We found 152 records for "Licensing / acquisition"

Articles

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

News

UK biotech's 'strong showing' at JPMorgan

21st January 2015

 UK biotech's 'strong showing' at JPMorganNews

Last week's JP Morgan health conference in San Francisco was marked by a greater sense of optimism than has been evident for some years, and the UK sector shared in...

Read more

Roche strengthens hand in antibiotics and cancer

14th January 2015

 Roche strengthens hand in antibiotics and cancerNews

Roche has entered into an agreement with Meiji Seika Pharma and Fedora to develop and market a novel antibiotic treatment, which is currently in phase I trials.The deal is another...

Read more

Biotech minnow takes over GSK Alzheimer's drug

24th December 2014

 Biotech minnow takes over GSK Alzheimer's drugNews

Bermuda-based biotech Roivant Neurosciences has licensed rights to an Alzheimer's disease candidate developed by GlaxoSmithKline (GSK) and is planning to start pivotal trials in 2015.The drug in question - called...

Read more

Antibiotics back in vogue as Merck cuts $9.5 billion deal for Cubist

9th December 2014

 Antibiotics back in vogue as Merck cuts $9.5 billion deal for CubistNews

Merck & Co has offered a hefty $9.5 billion to take control of US biotech Cubist Pharmaceuticals, in another signal that big pharma's interest in antibiotics research is returning.   Merck is...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Pharma Packaging and Labeling USA 2015

25th February 2015 - 26th February 2015

Pharma Packaging and Labeling USA 2015

The Pharma Packaging and Labeling USA 2015 conference will take place in Philadelphia on 25th – 26th February 2015. Returning for its 7th year, the well-established conference will present...

Read more

9th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

1st March 2015 - 3rd March 2015

9th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge...

Read more

BioPharma Asia Convention 2015

23rd March 2015 - 25th March 2015

BioPharma Asia Convention 2015

Asia’s biopharmaceutical industry is entering a period of opportunity; the need for industrial collaborations to foster innovation and change has never been more important. The 8th BioPharma Asia Convention is...

Read more

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

30th March 2015 - 31st March 2015

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

*The first in-house/corporate counsel attend for free* Join your in-house peers at the Post-Grant Patent Challenges at the PTAB on March 30-31 at San Jose City Hall, the future home...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more